Estrogen-linked cytotoxic agents of potential value for the treatment of breast cancer.
D000818:Animals; D001388:Aziridines / Q000627:therapeutic use*; D001389:Azirines / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D004317:Doxorubicin / Q000031:analogs & derivatives / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008325:Mammary Neoplasms, Experimental / Q000378:metabolism; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use*; D051381:Rats; D011960:Receptors, Estrogen / Q000187:drug effects
D001388:Aziridines; D001389:Azirines; D009588:Nitrogen Mustard Compounds; D011960:Receptors, Estrogen; D004317:Doxorubicin